29 May 2022 | News
The domestic business maintains double-digit growth in fourth quarter of FY 2021-22
JB Chemicals & Pharmaceuticals has emerged in a new avatar as JB, retaining its core value of being ‘Good people for good health’. The company announced its new identity during a recently held conference in Mumbai.
In the financial year 2021-22, the company has recorded revenue of Rs 2424 crores as compared to Rs 2043 crores in FY 2020-21, registering a growth of 19 per cent. The sales growth for the last quarter was 18 per cent and domestic formulations continued their market-beating performance, recording a growth of 30 per cent.
JB’s international business witnessed double-digit growth across segments with a growth rate of 9 per cent YoY. A strong surge driven by the contract manufacturing business in South Africa and APIs has been recorded.